We are live on
!
Find out more
CAM
Cresset Asset Management Portfolio holdings
AUM
$23.1B
1-Year Est. Return
27.04%
This Fund
S&P 500
This Quarter
Est. Return
+0.15%
1 Year Est. Return
+27.04%
3 Year Est. Return
+93.04%
5 Year Est. Return
+103.75%
10 Year Est. Return
–
AUM
$7.43B
AUM Growth
+$373M
(+5.3%)
Cap. Flow
+$381M
Cap. Flow
% of AUM
5.12%
Top 10 Holdings %
Top 10 Hldgs %
62.33%
Holding
1,161
New
145
Increased
742
Reduced
165
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ARK Innovation ETF
ARKK
|
+$55.7M |
| 2 |
iShares Gold Trust
IAU
|
+$31.5M |
| 3 |
Hyatt Hotels
H
|
+$22.1M |
| 4 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$18M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$15.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$20.2M |
| 2 |
Celldex Therapeutics
CLDX
|
+$15.3M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$9.52M |
| 4 |
Palantir
PLTR
|
+$4.79M |
| 5 |
RTX Corp
RTX
|
+$4.74M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 39.28% |
| 2 | Consumer Discretionary | 6.79% |
| 3 | Healthcare | 3.4% |
| 4 | Financials | 3.36% |
| 5 | Communication Services | 2.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Northern Trust
NTRS
$33.9B
| $1.08M | 0.01% |
9,977
-1,415
| -12% | -$161K |
|
377
Diageo
DEO
$53.6B
| $1.08M | 0.01% |
5,521
+803
| +17% | +$156K |
|
378
Northrop Grumman
NOC
$81.2B
| $1.08M | 0.01% |
2,991
+314
| +12% | +$113K |
|
379
CSX Corp
CSX
$93.1B
| $1.07M | 0.01% |
36,040
+10,496
| +41% | +$336K |
|
380
Duke Energy
DUK
$97.3B
| $1.07M | 0.01% |
10,993
+1,339
| +14% | +$139K |
|
381
TransDigm Group
TDG
$67.7B
| $1.06M | 0.01% |
1,698
+38
| +2% | +$23.7K |
|
382
Teledyne Technologies
TDY
$32B
| $1.06M | 0.01% |
2,469
+168
| +7% | +$74.2K |
|
383
Barclays
BCS
$94.1B
| $1.05M | 0.01% |
102,232
+14,709
| +17% | +$146K |
|
384
ResMed
RMD
$30.7B
| $1.05M | 0.01% |
4,001
+397
| +11% | +$109K |
|
385
SiriusXM
SIRI
$10.1B
| $1.04M | 0.01% |
17,128
+2
| +0% | +$126 |
|
386
Carlyle Secured Lending
CGBD
$758M
| $1.04M | 0.01% |
75,459
-409
| -0.5% | -$5.58K |
|
387
Dolby
DLB
$5.79B
| $1.02M | 0.01% |
11,601
+110
| +1% | +$10.7K |
|
388
Allstate
ALL
$67.5B
| $1.01M | 0.01% |
7,912
+855
| +12% | +$113K |
|
389
HubSpot
HUBS
$10.5B
| $1.01M | 0.01% |
1,499
+170
| +13% | +$110K |
|
390
EOG Resources
EOG
$70.7B
| $1.01M | 0.01% |
12,594
+1,180
| +10% | +$86K |
|
391
Labcorp
LH
$25.9B
| $1M | 0.01% |
4,148
+250
| +6% | +$63K |
|
392
CrowdStrike
CRWD
$218B
| $1M | 0.01% |
16,288
+184
| +1% | +$11.9K |
|
393
Cigna
CI
$74.6B
| $992K | 0.01% |
4,955
+292
| +6% | +$63.5K |
|
394
Moderna
MRNA
$23.6B
| $989K | 0.01% |
+2,569
| New | +$947K |
|
395
Mettler-Toledo International
MTD
$28.6B
| $988K | 0.01% |
717
+109
| +18% | +$164K |
|
396
Consolidated Edison
ED
$39.9B
| $982K | 0.01% |
13,533
-3,347
| -20% | -$250K |
|
|
SLCA
397
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $982K | 0.01% |
+122,914
| New | +$1.16M |
|
398
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.47B
| $975K | 0.01% |
19,740
-50,425
| -72% | -$2.5M |
|
399
Dollar General
DG
$27.9B
| $969K | 0.01% |
4,567
+413
| +10% | +$93.2K |
|
400
TE Connectivity
TEL
$62.6B
| $968K | 0.01% |
7,057
+1,202
| +21% | +$174K |
|
Similar funds
CHP
FAM
OAG
BA
Cresset Asset Management's Q3 2021 Portfolio in Review
As of Q3 2021, Cresset Asset Management held 1,161 positions worth $7.43B, up 5.3% from $7.06B the previous quarter. Its ten largest holdings account for 62% of the portfolio.
Cresset Asset Management deployed $381M of net new capital in Q3 2021, opening 145 new positions and adding to 742 existing holdings. Its largest new stake was iShares MSCI USA Value Factor ETF: 173,351 shares worth $17.5M.
By sector, the portfolio is most concentrated in Technology at 39% of assets, down from 40% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $20.2M trimmed.
- Cresset Asset Management's largest Q3 2021 buy was iShares MSCI USA Value Factor ETF: 173,351 shares worth $17.5M.
- Cresset Asset Management added most to ARK Innovation ETF in Q3 2021, an estimated $55.7M increase.
- Cresset Asset Management's biggest Q3 2021 reduction was Apple, cutting an estimated $20.2M.
- Cresset Asset Management fully exited Celldex Therapeutics in Q3 2021, selling an estimated $15.3M.
- Cresset Asset Management's ten largest holdings make up 62% of its $7.43B portfolio in Q3 2021.
- Cresset Asset Management opened 145 new positions and closed 58 in Q3 2021.
- Cresset Asset Management's portfolio value rose 5.3% quarter-over-quarter to $7.43B.
Based on Cresset Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.